{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "![image.png](data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAUgAAABcCAYAAAAMJCwKAAAgAElEQVR4nOy9f5gcZ3Xn+znnra5pjcfKZCyNfqDIQgghZMdxZMfGxpbbwhjM2g4h2Ak/Nol3Aw5xEsLu5eHh8vCofNl9uFluLhiwhUi4zib3ZomcZBMgARsjt4RxbGIritcSsiyE0GpleSQLMYxHPd1V59w/qnq6Z6ZnNJJG/Ej6+zw9PW911fueeqvq1Pn9CucASZJokkzZaudirC666KKLcwWZ+y4TveyWJeW4/lKZYYD5mI2m8+YdH61Wk3Tux+uiiy66ODeYYwaZaKUysNSI7xSVtfj4MCPi9t8WLhzY+sADt9fndswuuuiii3ODaO66ShQSM7lvvYj8B6A8/pMIiM4/evToTuDI3I3ZRRdddHHuMIcMMocgC9ysFwx3DBzVyFzCQBpF8VyP10UXXXRxrjDnDBJygdFyl4wiTS3egJPnYrguuuiii3MCPRedem57NHBk3A6pwLxzMVwXXXTRxTnBnEmQSZJ/xP2gaDjhrv00vTSigB12tVqSJNrcf/p+uiFBXXTRxY8ec+7Fvuqq+f1RT/ktgl40PogwbKn/XQgv7KhUsJwBJjNIr10G2UUXXfzocU7iICsV9AfnL4k5nG85//zYKpXv1pMksStv+uT8eKy0RtyWqU9U8U1cU5e9Mb17qtU7anNPWxdddNHF7HEOGOTUTJpKBa1UsC271kYLjh79zyL6bnefP3F4b5JzxLEPvrhw4Z/v7sZMdtFFFz9CnBMGORW5On1V5YLVsUT/CNJrlnXcUzXg+JfU7c5K5ehQ1x7ZRRdd/KhwTsJ8JqMpTW7dzlJc+swykBZ3HpcdAfcMkVAGLVerKHl8UBdddNHFDx3nJMxn2sHMFYrEmrbtPyQxtosuuujitPBDlSDXbwgqDo4grUTtCRJkF1100cWPC+aIQc4uZMdMLAhtzDH/lo7KdhdddNHFjxZzwCATXbuWCNZO8/sWBgdfUvhuCh75hN8mM8P2djfKp4suuvjR4iwYZKLXvq7/YrGeD7jbIBxF3NskyZZ/JTc9LkyBBdP5XNxBwETV8OwwcKJSwarVM6ewiy666OJscEb6bJIkWq0uXOkS/ptqaZ1ZSqsoxQxwU/f28J7Jxzil6LwnG/aDD2zf+rtbz4S2Lrrooou5whlLkCa+LmjP8ix9KXUkEloWxBm+TaTwnDsmok+L6iHcIxcxaBzP0h98bnvlxe1szetLnu0JdtFFF12cKc6YQbprjLgiolKECzXlwVN9Fz2kmdumyPyhNLhGmRhEI9XqnceongFzLIpg0A0s76KLLuYILQaZJAobIZFZMphsgnQ4W7g7ICaAqp2oXHfs4K5dREePthsnZ2BySdPOWS2+K5bTvLG5rcsgu+iiizlBziCTRyIWDpY5ursO5PnPic8QunM3ofgvZ46T2eSp2tB04iRJYkmSpDOmFCau44x77e6II3GZ0s+U0bEyvq+PTc/2Ic8tw5fGJL5l9ky+iy666GJ65AxyydJVuN7OYh/lM88OIQwjz42QygjKMJ6OYlajhzqhd5Q7qFPJO/Ai7Lv5fx7VOHO7CfdZZPJsPtwLe9fxmb2D4H286IuJWYTqAvS8BbgsRmwAGCTL9gFb5mhuuuiii3/lyBlkqsuZN+8OsvogIaqhOgqhRikbJUtHca2TpaM0pE5afzBJNn5m/bb7VGkP8p74/3TtcSapBhODIjvDvj9I+fy7kbCGtF7GrBfPYtwUc8vXd3AIEdC5AEYXXXTRxZkgZ5Alt9yg6BH1sX5gfsHbNOdnriBQ7jVOvpRWqH72rHVYY3bGSytFNBqLkXSQrFFInN70hBffbmiYZYdddNFFF7NDIUECJcgZjytNxtiEA7iRpYqQTu2mubPMsi2AIGKz5LMCmOKmHeMtu3yxiy66OAeI2v6eIthbirVlRGGyq3imlMHJ7bbM60ICzMuatSrsTlmXRrFZqeNddNFFF3OIXEXtIBNOz5CauvfZQ0TqANXqRH47qyK5XYbZRRddnGNMlCDbMUWY7MyR2r3Ys4XjiKC4r61UPnMQsrJpi0lm+olDpfTE4Wo16cS6p6Gviy666GJuMZE1+mTD4/RcyFWsGcRzOpCWAKogHzGyjwATdPbg8QF06d2Vyv2fn75WRbc0WhdddHFuMclJAy3GM7lG4xSHSwp5QLa7W3uwT4t1easHkem1cqHVrWMi0XIXeY9Qa/LHtmOno+cnH801wydt6wa9d9HFjwgdVOxTOVya8N2W1YdE4wXi2YxH5BFERidm5u75/sVPDmAZIEsta/QC9YnHdex9GhrPHJ2YVbH9HDCsRG+6aaCvWg29k3+pVDanlcrzx//lMMr2eW2d08SVMP+lnOuPEdoz485Vptnk7LvTHSdxhbvJ04anw91nXm+hSV87XaeYl4kqdrsXe4oGOy7iWZWKVbJtu2HwfZlnG8VZPC1RCuLgbgMg/ePVfMaHLAZpfakI5gBxTOvHSUzwHGrY0zHHczXWU08tKZ8YyX4f918uwt5VwAwipfF0tbrkvUmS/EQzyZwBJkYClSo6NFRELly0FtjNll1Q1P+05vz/JJ9vF2eARGxqrYV2VIqaC8nE9ONT9lvUmWj2u2VXG9/bDbuHLO+bKf1Ob4OcUqpxIiOrVLAk+e2HIdl62WVLykuXTkfd8wCcGB78UAjRfzCrRyAzVBGapTR4jpjjbbdtiavVY+sybIUIRhaADIJHiB4DHprrMYeGxqK4HF6uIbrYLVMpXgiRBixr1EulenzKTn5skWilglarS/qvrty7LFTlNSby6gWLfJkg/Rw7rrB4FOG4kR1av97/6aGq7CXWw5VKcnxGR10Xs8Omb61A9l0OGXhQPv2tnfzOq/fOWf/JIxFLll2CPbsq3yCK6yj3f2c7d7z8xCmP37Ir5lhpGZEuxp5dCroAedl8JJQR78ElxTmJ7x0G389nnjuI7B0i8eP5+DMwysSVnzown/i5FaitI7rwSk74UpA+xFPcj7P0woPw3C42P/c0YfcBEj/R7HN6RuU+KS6yybgKKRVyzpwk9tRTjD711LQUKsC111nqba6Yyd7vZnvWPvEp9J09KpUkOjR8qC/WeXeKh7fnGToOLghR5GZPcg4Y5Lx5wTL31C2z3BSRM0jLR09H53rAHwKaUmC1urA3w25Q4ZYS4Ro3WyUiKqJ4YcMW0DyyIeBqtZLqARq+AwY/BTz+Iz2Rn2Q0JSd/7mpCuAejTKlkYB8C5oZBJolywZJBotIHSeVW8BSIEB2hkd4BfKHJJzof78rRby9nXvmjZI31CPNxi0GLpBAthCEDF0PCMCE6hNsOFu39Mg39exIfmZZJLn52HRq/DS29kbSxGhFFFEQUHBzDHUxSotJBTP+SZbs/1mSSE+MgRVpSZJP5TG5PqEp2ahWoZVcquivY38QCFq32KVleJ/rm0ATZM3aeQkCQCCd2J3aIEVVkJsn37CCtOyEPgZrgiPrJxBe/uKScuX44aM/HwX8NfBU47hlmDSyr5x+r45ZinoEQ46zGeKuJLYcfrsnjXxaaaqUoqhEiMVEMOoPD9ExQ0lVIuJjcfFYGIkLUj+hNwKn5hKS9qCwDGaD5rIWIfBGWDDzL81OiHiWEftzW4PZOeno/TmQbedm+pR2rj21+9hqi8iZEfhv31WgUIZr32RiDtFgJQRVEIpxVGOsIvdOo2DBVahxvnzkXShL42rai+0nGw9MNE+pM31w7aQzM8WbON27F2+aHgJ9873zTrnre+endIfT8dpaNxTiKoHnWapvtuWi3NRRxQ+WAethd9Ne1RZ4NJrAOn7uKqYkra3dHHLN1pPXlxeJTxRgZmN/A//vcfN75yuHpO7kb5J2FFJfm6cRwgKzxNwj/E6eGiaLWh6SvxFmPllbgBo2xBcQ9v0Wj3s/CAx8i8aFxO+aSfZcS9XycrL4OMyOUFLLDGF/CfRduI0BMlr4c90twW8d5fQsYPvY1vvuq4dxZNNmL3ZTOxnmYTGqfBQwIs+lqMmMYyw+cvEs7fXMNV/WiMlBLqJbTZ+b/SrFlF9HCkfR3Qii/O01PxiIStU+d5Kq1tiWdGoKKY/nLCEXYWS8xVKkkUdcOORdwxl/ycyk/vhAW0Ft+HZmVUVXS9CuUoktxHyREqxitryfxvwdmthU26z3kmtROTD7KC684NuWY+7/TT73+a2j0XsxXkDViSvHtZNn/4MIDnyHxlEXfHsDlA5hdipmhoY5nW8jC3bzn5QemjJ24sujAcn7w4luw7AtTnTQT4iCZJtJnbpjDqXtpqdo5q+yZ0OrYyU+usNUBk+M8f7JQLOi2lhDdlqVjfcJEdU5EUxE9CLbHPT3miKlIHxIGUF2M23KgTJb+c2znDXdXtpwrTHSyzgkSMe57bjlZdmmxxRC/n6h0F5ktQAOkfhNUv0Jy/Wm85DwizSKuQ0naH+674bsrhlny/B+TvZQSlT5CI+1HrZcQ3sBIbQtUh5CfWUccX06jDhqBsJVG9hGGXnFw2kLgL6w4SCL/9+TNp1Gs4sxQVAxXhe+rBMuQIrB8qoMGwAUTFBEZcer5pJ6qNNo5oHvSALPeczycZdK24vuslZvJ/Z+q79kEn7diECfHJZ4+vdUqmrpfEcxX57p06zeRAOJfERu7B0r76uXGcM+YGMRlPOuzLBuUwKVo6UqX8Pj1679bb94/pzqHs6F5ch/5N0yOx5yu/5lspDPRM/m4TmOeaozZn2+bdjgXKnYzHCYK1yC6ODdLZUOkPEpmr8eya8hSRaPXMPiy5SR+4LTjIrdhU45JNirPL6mx8MBfo+k7CKXX5GdkawjxAi5ccZyxxsWk9aW4QVwe4eTI3zH0qoP58dPQMA3j7BzmM9lDfJYe4yRJ7NprP/Gwp/V3hKh86cyKtqu51zJPv9DosSPAYO5JnkRnRw/73KEps+aUztx/O5NKinbTNzXl+5QPcbOo8ERUq2iSJIz3P8n5Nf3DO3176kOXKLPstxOSJNEvPzHQW66Fi9ysb9zmSG6gcLNhj/QDgeN7Ad5wVf6oVquMAMe2b0/23XbbliePHv3eFqE80hw3/y5oSzoO3U7EeJhFqyrU7BaBa55ra15a85Mk01/D6embpRNz/LgZmanl3uDmhsljnQpzrJWMMxq/CRUgMpxvsqh+jO/V/wcS1fAsJu5dRnbychLZf0rypqDDGlOJ5PNwdOMQS57bQ6nnNaR1cPqwrJ8fSMw8/Rncy+ApwgjoPujAbDuez0RMVLHbvdhNJjQeG3l2TOjrX//9pyuVe/+NWe0t7lZkjDTvvxZt4sFcbU9w2f7El39vhJvfNJinNLbR1ZG+uUXrwW6Xb6dWLE+SRLfsWhsNHj0yuH7Dp1bLtvCaRwivuA4WQBY/4jricOhasn/m2vt2fPnL6QFg+HSlnaEh9KuP9i+9Juu5YSty5XUbfCnmPLJN9nuWfSPL0scrleRwXhkp77dS2bQiwy/11FJVVVOxrdsye+3rP7Xz9a998UheZm7higy9/LrruQp0BdssAj3yCPbPlcq926vV3j1JktRnS2vISmURHURzb7XguIuJBpzs4Ne/dmRPMXPtqvN43xddtDtNkuRYs33ZZZt7zz+/foUZ860qputVATz69KEXLxh8ZvDobhsbmz9fe3rWbt2u16x3+XnB5rNBRrZW/cA1lU8+GNGzE5ITM9kyK5UkeuihRQPr19+76pFtevl118urcJaSe2VrW6scuZb0Wat86tFqNT5QqeT9VSr3l2H0cjMbaNJnKqbmCvcc2779vY91GqvOwou3bpPl11TMqIKuV0313oOPVe/aOXX/+8uZ1i6Rbb6Y9cWEVc2iikZZ+OTer3/t93af+so0X/fMnQ3yvj2X4H4NaUMRMdz/jtsvqrP52R2E6ABuq0nTAcRfxyef+wrHV00fjnMmj7Fbffx/kTpRGOWkKm5Riy+IgkzJUJstpqYaTpYUJ4f7nAWq1buOAPedar9WDF2HHzvSdy6NkNImQU50FiVJol/9av+yhfHRm116flHcLgcGkOZNEEAEcVdcUonCgbLKX1+74dN/Ua0e250kSZ0OaB9RALFQvmBwwVvUone523rRkN/iWkjiwm9GpWg7LL4HfusrkEuYW7dlG5Tojzx4DUHVzUTiUW003l+tLvxLM26UEL1PsHUQehGseY754pPRPhi9p1rt2wIc60DqjBhfkUhcPU9HXXbttYMXv+51Q8/kNHZUVydsmzcvW+we/YEIl6q4oYCLikd/0//9F38XLlhe6gn/HuRmcVla1CzNRxZXNfl3HvE3kl2wqVJJdnZikle94Y8HsrGxDaUe/SWMG9xYIKoTGEkeiqcaiR5w2Oos+KvLLttchXqvubwHid6q5PSpuEnQ2C3aWakkV7WPmSSJfvUbFwyW0ujDbtnNiqSIqASNStjDwE3ttFUqj0Rp2LU8ePRRd7+6SZO6mmsoq/EeYBYMsg1z5cVWuYFSOSIdM5BDYE8CUPf9SGMvImuwFOLyJdjoCrj7mbkZeCMs291PI1pNVoTqiB7ETx6j96U6dv4xJKQgkGXzwS7jwgMPkST1001TnL4e5GScczvfRJyWLekcO2m8k/yfJFqtXrA6RPGnIPrP4De4eb+54Vkzxq+BZ3XcU8AjsJUov68S3Zux4M1ffGpJOZfiOp9MMeWxpPZOJXwUZL27q2f1vN+sgWcNwMuOvxENH69U7nvNuBqdaU01KEgZJ0aIVUOs7ksz+A2Nev4Q/Grce90LWpv9muFuKyF8xCj/1k03fXL+bOIR43qtbm7H3a3wSkPLbCD9ov7Rr1YHr9iya+2kJYc7I4rE0JCiGmHEOLEEjZQwX+q22qV0r4j+O5ylbpm25iWPrQTvF5O3u0QfzbKB1ZP7r1TuXRzX7UMq0cfBf9VhgWOYNcav43if7ubmy8F/TSW+5/zz7feGFv70sKg+JSKG5/RhRSygyKpG44LBibdNYpr5MlFdKSqtawORO5dWKpsXTKRvm6mzGMIyEYnHx4AyeE1cpkioM6KIvT4rJIly/3f6gdcXy6AoIjtI64dJXHnx+SHcniCKR4EU95WIrJ05x7oN0wljSaLjtsK0VKHUs5YsNZAU9ypmx3j+sjruu4ii44hAWu8lKr2Z2tjVrL0tym2ns4+rzXecHObzI8aPX9zb1HmpVC9YnRE2icrNbul890wR0yYrLbJFtJ25upu6W+yZXy4e/vC8kcbNUyWacS++uhuOrBb0P7r7cstSLVxammcESB5bKK7uZu7Zmgzf+NBDixbkc+i1PI7eQUxx1KwRu8htKuH95o1lZinuZjjmbX2Cq3umjs8XLb3rByd1PcwmaPv7I0L2zyI6MjHeFXAzRG6MNHzugqGhjZXKp9aQd2rkJocpfTcaYybjBUscxNUtU7N0tbr/IcgVbhYVvNha8yKKgONq1oiRaL2WSu+f2HuirtHHReTd7tni/HwzBVcBXFAR1bbzUMSa46+QEH9w4dDQ73iWPSOqRxAMseJ6ZIjo/FJJV7aGK87RwnJ3W+qeX5e2/QfNGmsLm2lrPlJdhtsCt2J/DNEA5nvghT0zX49JmCsnTb1+MaXyGiw1oEaWfoOFHM+LSVyfYjwOHMctIksHiEpXMbCvb+blpAtMJ4s1+cLi564h6vkAWTqAqqL6NHbyAY4+MAoYFu3A/BmcCDMQ1hJKH+NY/MbChpnHSs6Clok7zCgl/ngwz444x8JtK+snI0kSrVQ2rXDCx1R0vecXILeL5a/nVELphIjsNfc9IcRDImEiE/RMRWWxEG2+9nX3XXLyZKaTw2HGz0noBe/L/1VUo1SQnKG17SqCmmdpFHpeE+L0LUmSqKnXJ3QoqHtWBrnULFuGmZL3aaKKeMs+JCKIiLplkWe2LEjpjmp14eBkp087kiSxSgUT9+2CPi46yd6UF0lWz7I1IcT/u0v0j9dtuO/Prq3c9+bXfnXJsi1b1kaTmWSppOZNHWe80ImD+EoRvcIsNQRVVUSDFT/bhIQrcfWsHrn7r61ff+/VkOhll23uXV8Z/AOV8KtZNtYLFo2fN2IaolGVsB9nt4TosGioC0W/goJFWVbrDaXeD6Csc2cvIupe3C3uphppBs0QGBLy1Etcf8GzbAGeL4ZXVLMy1aAeqOQ25MSqVbRaXdiL+s+6Zf15VpxAca+4yN9Xq0n6Q800ShKF65RM14MMgqRE8X5UHmf32nSciVn9ScZGnyaKQQKIVuixaSs2FCgW4ZMyJZayaPEyNn1rBfftXcnmZ9fw2b03sOQ7mwjRf8fSy9EIgj6O1d/LnWt35IxPjLtW7SPLPkb5vL2okku5cimBv+Wz+/8rn917Awt3D0JVT8UoO8dBdsT0XChx1yLwfE6QnKtyTKeBiT5yz62CrrlDRl+8WQjXFA/nuKoooiaqO71R36QavknGaCb1derhXaJhvVsWk8cwqVlmqqV+Se0DIZTeZ3gqjk728I8nZmrY75buMOe4qi4vJKeBPPOkuZdHZo35SrjuoccW/XUkmRVse1IuRe52EpW6oI+aNQ4gUtYQXeKWXTJZzc+7tyvAlkFy5NRe4Rf3Zb7gc0HjNe4sds90vB6ooI5hWcMQ6ROJ3i6kb45i/+bCRcf/qlod+AJwqOmpbzTESrGk3kZ38yxwN5HIVGSve7bTzU5I0NWIrMOy/lawQ26nVonVqN8CyWPnnffpimjp7WluP8sZjjuCGnAo8+xz5tnfSxSOq9sKcf6tiLzV3fpaHmGP0sbYAkF/CU+HNET1jCxu7w+4qDlfCfDahs0v9ZTWuhvuaZt06nlMs8vP33LL5t4vfvH5WrWKXX2j9pbSsAo3xX2cRvdsGPWvz3wXT4OzYqcb4WX7FuPhKtJ6nKuxjd00xiZ6qe+6aIRNzz6I6M1kYyC6CgmXksie6SvxCGCgcjla2gyhmTgQgffhtpigfWQpwGG88RUyPs6RVROl6MSVIzzEon0fpjzvD2iMrSgkXSPSd5Lpmyj1PsqSpV9G9lQ5fGR/EfIwTbmzM1GxN26EJOETu04ul2dH3+S/IhHuhoQzn37PDAKf+NWxR39/Tc/TZ9zPHKAV4tPGpAQbPHpk0CX+JfD5tN9qriYiJ9wb/3HDhmOPNjfv2rX20JEXXzyo5veAXOHuxUPratYwDfE1sTQuMbfc09tWetidIutEdpqnH80auj2ObbQRxgaiLHqnavR+t6y/RbXg5mgUrQhZulhdzCfFIgKIYwh1N/usRX5P5DIE9ahhsiYS+SOQi/OiGQV7dVPQxYJeDDyZJFPDh5oowmSoVuVLnjUGRMNHRaI+LyQ9mhlJuRqf21CFPjeviMrlaPn69Rs+/alq9dhjlQo0GuDixaJtE9ITTTQC829CfaNQ3yk6r4bbYkPuFA3vxrK+1jUS3DMQW1epbF7gkv0i7oMTcyDERMOwe/qpejn77BNfPj5S/HCgUhnYax56VUu3uzVyVb4ZDKa6yiwbVbeaIHFz3twzcF9dqfzU/GolGSZJrFTZNGDua5quxXH2KCi5mr36e99rLAP2QWKa3dcHvpKiDB5Cs97CHjLfe0axn2cjfiRibPrWKuKe1aR1I4pr1Eef4OjQMZKLWiXDAHTvw2SNEZBeNJSx7A3A508dD6n9aLSu+D9/EIpsXxr1lHweTiD+jwhD42M2+22mG76w6i9Z8u06qncRxVcDZRpjIKEfsVuReAORfpNFS/8W+/W/hOTI5MIas3fStIjPaSharqzE5f0CH0T0g4h/UNo+p9NG9QOi9gF3W3c6FJ17FGxSvJYSLnbzy3MnRpukpaqI/7Xasceq1evG4yIvumh3uviCC3YiPCAhGqG4PXMV1k1hIHO7HogmhDMB4KYhOu6SbQr0fimOXzherRwd/cbDJw6JN+7DssdEI9zb46QwdwZClg20r/Mz3qNDblPXrZbJPVE2dLBaPToK3x95fWXom5h/yt1TL9TUNptqZMgrZjNbuap9dHRkJPoTJ/tdYK+GWIubfeI5NhklmbpZn3t2q0rPPSkL3ghAb/uuzZNonoupB7sbjldh5ESlcnQUjh5Q5L+CPENbFXvH86ElLDUdW6caX+JmOm4eaaq41tiRxvqnN13ZZI5JEat5/DCBexxLc2bbJMrVzfpBBtzTWq5mA1DYFcNSiBZX8pU71Sxbi2XL3QxcwN3cyRMn3Ey1NKAlXdOkO8p8qbstd2tZs91NPfUdUDsx1ck3C5ypCJO4cv93yki4nLS+vAinOU4WHodKEaeZaDOPmedX78PZQVTKGZzZhsK5MzM8HSUdO0ha309aP0BaP0jWOIGIUe6NCAFCWM28+R/B5HMsfnbdxFqStOIan/+fX6KR3oll7ydLdxL1KFFJMQNPe0nTDcTzPkKJTWzad3F+bMtkMdFJMytPdfHMFXMgSorIqED+cUZo+0xoU7RpfSb9PuowKh3X3v7hYrKKXbzv64peJyrz80IWkjNJF3PLhh17II+N22btQc4PPLA7bbhvxX1IhOYDhLtoljV6Bb8cvJ/2cnCOiahmWX3Ig26tVr9br1aTwsaTWLX6vhMmfFk1dApk70uRPjWxKdIjmCg1cftiFA0drFQo+kvSJEksy6wqovtVWyFN7m6ImogOMkskSWK33PJ8bfsjd/1pGuQNZul/EtHdGnpG8WAgaev9InnxCnE1y2K37OJI40/Bomva+2wG0DuF9CiyY/vWux6qVpO0SX+lgp1/vu53T3eIaJ2mKNw80r2XNLrW8pTGCVCNMOVvH3voPUNF8HdxbP7/9q13PYbzpIQSTAjeFVWVsjsHRQPgzegzk1CanyKrxvcN4ToJIXYc1Qjwb6roweZS9OY+X+DSSmWccV+C+4LcOQOCpqLhmEn29Wrl+8OTVwSdHs2XPGcnQY6MDRDF16MaUeqBsZM7iE7sbDk/ig9AIinIA2SZkaVQ6lnOWHrD9J27FXRuh3Ataf3nSMd+lpPRzxHkZ2nUr4lUAr8AACAASURBVOXkS/8HIjuAlNEf9FMq3Uyp9//js/tvnVJkNxEjuT5l6JUHOLzyM8ThtaT1X6Y+9nlK8UE0GGZG/eR8gt5KpA+y6G2Xw8ZxJjnNu8QnqduT2y2IuYGnhtfBUnJ5tPPH2769rQ0pWNGWVPxUl3ASPefAf9SxSyNCfDWiJmBN+5yoIqqHTfwAdPbC+1jPQbf0cBFnaOMrO4orooOO9I+rn+MQBEZcs1pnlVYONetHTiyI45GgEaRtFq6m1wIDHcnwY3n17ok9RlGoC+SFSGWCGwiE0yrc25yHbzx858Ht1aGN4v4rno19VFQeEo0Oi2hK4RgaL3snglmmDstd+DCjcVSYGZjw2hJBjCPFSBPu48sue76myAtISPPzLc5B8nMQZRVu88enq/g2S8F9GtNOPoaITPrdEcFAyiqyF3dEirAmwRR6BVlRrWJr1xLltlyMgkE6uh2V/VLEznrWKLv5RbCkH8Al/KxoZDhWOHNURA+QsTe/dKeTauhn96wkYvREK/BsXe5gQlGG8f71fGbPGyd8Fu99I5959k14I8ZtBFFDxBC/iS27TnEfSUqqdY6uHeWui0Z438tP8K5XHuLoXzzO0OGP4GPvIEv/BNE6acOwdDUiG1my7JKOITxNafKOl9c48ud/g/a9i3r9DtLGnxLFJ9AI6jXQsJhS+WMs3bOqGZI0UcX2JuMZt8xPbY+jzSvj1BCpC1ITpCZyZh+EGlBDfHoJshN959SLPSFPPHZncOJdVgwucjzKQsfAb0isp+fQMHBMVWkvC+wO4tILEkNhMyzGbf2djjKvNfdoUz+104RMYbyGTX64kiTRRqTmkp9H03c/V2+gavWF3SLH/ou4v8fTsd8F+WNURmj6porxRFDPUhC9JoR0DWitKfw0YwUACFNfpM30wsyzurTJSs1XiLur4QvcPPY2ppFL9lkaEXUMiG97kRwZZw5FzwV6Ef8ndxsZZ+aOmmW94K+47JYl5YGBwWU4a1pFkQ1RnkD0ADC+sJ1GpeVZyJYmSaK4r83PurjOKlia7g2hdPA0pr5F55nGQTbVV/cKyCCWKY0xQ/RWouiPCD2fm/iJ/yj/lN6PWx9uSqMGGl/B96KVM4fYOJTHtPOyC9uMw2v2kcUfAdtCFEd5LCSXIvqOZsjYVPrb7J53Lh3lhVXbKcfvx+obCeEQGnImKXI5pu/gwgMxietEFRumMsJTqN2ipDmDo+ZCzdXqLlZ3L75ltm3qAjXwus2kBHSi7xxGII0/jrnEGkkeqNuyXTVvXJd6o6EdCysAVKuYIB0YqBgaVCZyiVlh5uq92Sn3mA06BsmfEZqmgSStVF44uGHDi19qjI1+yN3vEuFA4T0eH89xVKLY1K91UqWI5/TCwTPZMz89/cW3FDpsXso8br2AJrhL0jRk07zkmpCxcRW6SamBO+UU9uCyVzQycTcH3LNYkRXn/yCdLxGXiJb6MENENEsbdXWextLv5jZJDMHcWCoNX/zEE6v6EFbiha3U3VTDCGL/dGYLuZ3FszLOYPQNSGFL1qBEpQFgGSJLO390MSGKgNzuV4oW4375zI4agU5l9NvV96MrhsjsHiwbHY+Qc7uVe3f1zZgt01L/jRUHRvDz/gRr3IOEEUQhrZcpla9mNFsGc/AEpSmIWj2gGJh625uh+aKcZdudVHBcT9MGOUfPcLWKVSpphER9orlHeFzykkLddclVhZz28ZqGDr2lkk3jUUy0Urkwdk72NVlqy/nh6m41F6nLhBqJZ4hxlTLMvN8s0KJzbkX05hxVKsnw0MJlWwaODcVBo4+5Wb9IW9FVHHHWgMduTRUcaIsBPRXG59llvOakC3VEwFrsMZckJY4yZszbdbfzRbStXsr4CGnJ5TBBtnor9lFxjBAPYukCsNeqKJm4iUQK2d5K5ej+rdsu2Ccan3DL+t1dRWxQRFaMjIwckuCL3VtXwtyPoZxe9kzz/Jrc8UxtkPfuvRT8NWSN3K5kthfP9mAetdJrOw3tA2i4FKxMo94P0ev4+D99ie+fGMkXy/r26dHRYq5P80f7dhNK64qCFSuQsJIkyVMaT/UCuf76lOQRWPgzX6As/waXDQgpqsvRxjIS2TdRxT6ddMKNG4tDPBWRmkNNoO5IzZGaS/E5jTbqNReti4fTu4RzJEHmapSWaa7SKC0lU3Nj4xFROdQ+Ty0Hji2uYx09dEkCjdLIgIsvNjOgXfoUHDuheYXjlq3wNJhS59PPOM3whNPs/9Q4VQBztZqkg0d3W+S6WzU6RFtgeZ6P7gAxPiGb5bTombCvkJfTcx8SpD6+zEfBdTVEajbVeVOcSxF9wEpErKm+53lNggjHwWrm2T+4pXVENF9SRUxF+qGxGPe1ZllhRwSQJ5MkMXU9KKJDCCaCOl520VeGYKtVS3mWkGOiQS2r71Orn17udfPkzxYRNxKXI/KMpRouG3n+lb+Enn8bPaXpP0HuIpSeyV9KppTii+ntWwnbjLMNoHbJFwVzz71sQeaf4ohJqBiMHaFeP4Bqmj/O3otob37Krb9nhsjNTWuKmEEuR07Rfjrxu6nPjpF7XSU79xLkxLp/UKmgSZKk69dvWolk42EW446/nA8edOGo5OEhxc+Cu6mIDqpwCbBzciB1ksD6DaxRiRabp4wvN5BXuUnF0n2GRHqGrOicmmDPoP9OZdSa8zxRwk40l9qzMnh5siMwd1n5CYR+0dzHebr0tDQANHegaOruB1TCCcda0qKTB4wrVyVJ8qVOmkClcm+fua+T9vvZx42jB8BHXMMeNfYDa8wzlTy4e74RLhVhZV60Q3C31Mi+AZAGORwsPYSzGjBRAdFV7vYDFaWotI5IhEj69Wr1fSfOrIiwnNnNkiTKsn/fT+Pk68kaoAFE9yAndwDw/JJa5wML5jfwjv301J9Gw7p8jRlbidvFcN0cxDrnWWb5v2ago62c71nWg4t+2vAf1HKeZNY+SR1Y48RMjqntAm2MXyH1fGU6y4qU2BwtBaa1TSe1WxARyzNWbAYJshN9p4/JD0ClklCpJLr1Eb9LVPvNsjw+zwsmaKkiPEua7XMNI7j0uuQ5u7ntSGNxfxvwp8UImveLwoVRaiOvV2WBu1vTGC+CqZaGU8+eELefZ8JbY/bnNc0V4mwtKGf2LCVarS5a7mK3O/5MpXL/1mr1jmm88HDllQN9mcstkqYrEJ9EsIDotwS5zJuhQPlmbb+zZsbE2VEJqWm6C5FDIEvHexHUrAGU3vjwwwvur1SS/fnSxq2eTLhRJVpheXC7FhRansrOznovwyHzuro+jdvaptfZ3frEea2jA4ghqoAcDsiTAFHmQ+bZXtFSxTyFzFXUVpl5LJKNu/TMGmTIGdZXPxsv9kZo7LuEnvJqxk6ChgjsSYLlDq0Z6ywmyvFVIyx69h+Ie9/C2EvzcesnlK/ip1Z8gUsPjHB62eQth9GSvQO4ryJLc6btNkw9O3L65/eDXlwGsbQo2yajICMwOdVwfIXA5k0jrfY0T4umpRTSmqOWhzugrcfcaQmUxcbJAmZ72y0X1CSawYvdib7ZY+3aJB4cXHS1iS/1NN3nrieiKMRbt/pKUb9DVG81y3TcvuS5ucXhYObp0yX1Iy6lRxG/Ec8lcgTFUtMQ3bi+cu//1hjr+X96eg4VMWoLyyYnbw3S83bL0phchcpVJtHIspMHAjxs8PNeLHrkM7C8TpjgZsgdSLTbICevHHk6aB07OyRJYus33Ls60vPuzGxsmVntmfWVz2zH7B9V2Z8GhqJMLAvSGzJfaeLvwv1N7lY4UYq5QcnS2qiKPezwC+30nO55tJ+/4+oi+ywd+6ZoWGd56FbO7NxNlLUhkg/Coru3bHnhcJKQVqsXxnnNR/+ISRp5U5b1XMbVEO03sr+76crjI7t2ra0NHRv6Bwi34pTzQPJ0PrABsd7WlZKdwJE8E+aukfXXf/op1WjY0rQ/L4jhqwVZbtbIox60hFu2uyRHnzytk++E5vM203KsTSSee5Nl6XqcBagaGp2g0djG80PD8MDMYyWJkWxULNpO/eRhRPoRNczWMy9dyrZte1j0zkkHzeKhXvJ8GdffptSzgEbNiGIwHuPFVUdy73el5c2eaclZqkr2skvp6bmYRj1Pa/TsAMYhEtepSy6cUT1IrUsza2Py8ZM16RnahhgK0YTg3kk4i3qQuXTzU72m4VfE7TcJ0Ql1GTUhQhlAQtkss0lDGGAisr3k8QGIR8xH/0IlrMN1QdOp4DmTBJcPx3Hj1akt3HbttYxmLlep6O2epUvBtWlbaxaeyCz9XP1kOtRT1gjBcLS9HuRsMZVlZMW8hDNijNB8lGdPS5IkumULkWSsymx00N0jCdGlAusMUhOGg8mwo6mYlc19UDXEmRW1KNqcHqKKW/b5RoPDUezllg9b8NNw0sCkF4N7/gIJ/ldCuFHUV7lleYiNoG5ZJITbHR+8YHDwi1+r+rGgtVWWydtEdY2bjWsADiaqdcuyh+aVSzvzEKPd6QvbFz0j6BHwFYVwoUBuG3Mxx8zddo6OlIab8/a17faMWXZCkCKHXGKYGHcqKtXqI8k06uypZ2EqNkIyUzTARqCqLBlcisZXktbLedSF7CewO2dC15/aX5CIkTxygMVLHyOetzZP99OVqFxBkuxm0+3ka08V8OKZvo4iYHsjucpaqM6Lvr0Az94KelcRagRuJzC7H6rK4LLL0W/3k922k7suOjI1pKjoKxHj3r2XEOR3SRurwYxo3ijpS9tYYIcY6iRBTodpHDgaxtLM4xqSV0M5mzx4AcMhUzk9G+RpPC31uBzHKQs89zAOoDIghSrtZHnwdrPb3GZlInoos/pfBV48AZDFi/5eG/yChNJveFYvN1W+/CR8vov8RkDfCpK6WX9epqrlnRUXE1V1S78QGPt8Z4/zGbpG5Ix9lB26On0MDv5Ur6Gvxr0XUMtSy/3FROLaj0o/4uNOmMzSybdWKqqK2ZMe/F5ixnn9mUnAHc6jAcdeHHx84cKhTaLh4+QRNCYi6oJC1gv6JhWtAKPu3gfEZqZ5EXsHxDSUEOdxs9q9Dz74nuMA1eojkbL7oIscQFg5ZXwRUwnHzPyfb7nl+RrkNuqr3pDuK9X0gGi0sjBUNZlwbj7FasC2fP8zWXvHARRLI5yL2LT3ZngO/Fe1df81K+Y3289C9DLDWIPIxUVoD2SN3YTy1NUBZ0Jyfcpn9j6IZe/GHUKIsfQm4E8mO+EQYsT72D04zIW/njK6OyJ6Wxn2LiCTdZTC67HoTbgtAIworuPp54nqW7lwRR+mb0PCrdT9m2za8yD+rd2kpUMMMMxL56WE28qk+xZz395LifRdIFdjmVEqK86TpKUt7H5FSlIwtdmZqjo/sHWLLcJriMbkthhMMHVTkyh32bppvq1gPqKFimJKsX+zPwXIZggU74RZPjdJkthrX7u5TMziwnsMnqdw5fbrdkkjV/5D6BnNvPG5gD7ctpzB0A03fOIPGo3yAo3i2y2tNyWaXDV3U3fpQ9wQz+v3FZKPoIiqmttXAvLhavX7w5XKwl6bUUL/yUA+v5+YX4rDxS5mZm0vnPwFpLl0MEntzf/Ns0tCrJ6lzxD8w4svGHzm8IkXFnQebXbocGtYCKndfvvu9IknBv7kpZPyStHwW+T1N1NBiqfBcJMyeWFammuku+dZPSGU1PG9Da+//xtfP76nybSq1W122WVLDp/Xlz4jGq5xyyLaXroI6iIHVdnfnDOAN1yVnPhadeGOoGFDXui3FWCV2yzZL954uv2Y00I+x0paLxNKt1OK3zTrl3CWlUkb/eBQikcYe+kJDi87cdqLcIlvJ02PoNFg7qxhPZv2DY4vP49ofhvI5YSwGWSYWqNOiCKM+USlBZRKg2SNATzLmWpcTmmMfYGGf5yja0+waM9yovJrEF+KyFuJz9uAZ8fRxnFG/BiM1ElLfYQwSFxaSv1kwWR7FPchxkY/xNE1+5vnNlHgG1dX2yeu2e7MhcolTOCkZz7q4qPuPiomNXcZFfOamNda2/Lf3bzmxfb8t3w/cR91l9FsxjjITvTNHqVSvdexQciZFS4mxSdPe5O0CKlINcRDDat/eNEFA/8lL4TQujGvuebEIZEjv25p/ZOi4VirTmOzVqNT2NVM0BTHVCOTEB9yz/6vQPquavU9z7Q7AYq0RcPF2p+pjkGzraMoDMtN+ovtgbT15kvHf5dgrRTCTjjJeICqF7RIUQl4Fo9DVupRkFS1NKIarIitMRFJBTWcPG3O1fJ2HjKjoZRq6DnmWf2PLbLbtq8/+vBFF+1uuw/yfvL9i3Oc1eOpNK9JM60xyyIFuPLK4yPnzcs+hGXvFaI9QeNiPClSIL2Nkef0qqppKJ2wrLElqzdu+Ub1xR2txcEAEnvqqedruD2hWjohzb5a18c8G9sD9XEJrOn1D/A1MwMN7fsX9gd/cmysMTQ5rXLWEPL7BAHL+qifXEy9NrtPkzlqgLQxhPmjpx2ek7hy56uOoeEhQpQ7Yks9g3h6I9Rb9ImmqPQTQoWo52ZKpbcQ4lsJ0QbMLqZRGwSUuHcUZD+1l95Pze7k6CtypqZaJkQpUZybIhq1ftJ0JSJXEKI3EUpvRsONWHYJjbEBRCGeN4LZwzTGfpGjax5vJ7tDPcjJjHBm8axu5BWfFdP8T4H266gdtnVoN3OwZ7JBdqLvtKSvKBL0sKiWTaQPtzJ54QkDqSMyjPsQlu0Usb94tPrbDwM8MMkWXTwQtUrl/g+kfvKL6nabhJ5LgWW49UlegFVB6yI6jNgRS9OnTep/dnxo0WO33747bYZqnH9+ZN//QXZYNX7aMFQL35UEGo2TB0qlUsfsjgaMlDXeIRN0VDFERyRNR4AR1Z4draI2CrghOuI6Ntxxek6GNJSj/aj0mQYTXB1MpaSucqjt3Dvi8eoLB6+5ZvBOVasgvFajaK0QBtyZD152L7SWfC2WuiDH3bMhz+o7UR5UOfbQhmuxR5PEEhK9+sYoVQ0HBN1pmk2gJ5NakW43MaQqSUA0OhZC/DRCLG03mkjpsPjJ0eYSq0mSjFSrfLbuCx8LJreFKGxwD0vzXG0rjpVUJIwAx9zGnvEs+++qjYe2P/q+E52X+YVqlR0i4fEQlZY1tzuYalxv1EYeqX69FarTCpy/d6e7PR6intjVinPNXyBpdvJrPT3DwzOVmpsWlg0T9T4DVj4jI5ijBUNTRr/3GPN69p7u2i7jCPwVIaxFepSe82Cs9mpMHqdU3oPQh3kZiPHm85NnF0GooTJKo3GcNN2PNZ5ArMp7Xr13Qmrh86v3snTPHWR6IyLXEc9bBT6AWR9mEZiimiLRKBKOU39pH7XRv0PCF3jPq4YmO67yJ+uze2+g1LuZdGw5WTadwp3r6I3aX/Kq//W2ZFvFkkTs4986uQLxN6vPQV5b4eixzKvvW3teHmN1775V9ER/i9uaYvW0Dge6EfVAlj3N83922UwXr1K5v5yFk6s9s+UqMmDIAnWPwVLxMOyeHVHVg8C+SuXo6GzVmZtu+uT8kZFohUS+SmCxYX3iquJ+3NWPqLf6hElMJkn0tV/tX1YqlQbaOWFQVxdGouzY/k6LTV150yfnxyO6KgstVScGsiAWsrGDJ08Gi+Ppf69W33dicp+33bYlfv740Apx+jJrHRfU1cZKx77xjTtPmQPcZBqVyr19WQjLQ9YYNNEBy7yfQF4d3RkVYVjdh0APQe+havWOGsWSuW3ZNhEsXJGpz59MTzAZrlbv2teJhqtv3DQY123p1DeLpmPn6/6nvnjnuFzelOB27VobHTl+fJVYusKdpYL3g0YOI2I+BHJo3ryePQ8++JvHTzUHt922JT569IWVmUpvO90A3jN28B8e/A8d+kj06spPrw1ZiJvX7FTXa1b4410D1MMymqnFTWGoUXzP1G7/PxJljCF+75WHzogOgHt39SHzVhIKPpPKML3hEA1bTqO+gCjqwzxGPcI9ArW8iogWoTc+hDeGOLo2v36d1PymY2fZoX7Sl1biuhjxAdA+3CPUR3E5TqZH0Jf28Z6fG5qO3JzbbNqzgZ6+zaS1FTmX7Yj8DdKo/w090duS766oJ4nYJ58bXeaZ3+yEGMfOyktjBqpIJtX3ru3J04U2P7sGjf8WfNW0DNLdKPWAZzt41yt+YeoOE9G+/nG+ZOtLOjT0Xbv9dtL2dZFP19bTYgxJBBcW8/jdZimufK3safucSXWa/phKBW0vedUsk9XcNt3veYzf6fU78zEdeimqgrevTz15/NYa3zP1e/r05BELE49p+3WasI8Wc06SRHftIjp69EJtv4ZF37Ocg6nX9NTzOPGY2V2vU5Exi3VgZoWqwjY7Y+lxCj3NcJxpajlOe9wM+0zYv2CUrf4Vqkwc8+4ZUxJzbrP52Wso9W6mMbYan4FBaqRY+ijiv8Tzq4+TiG1+1hec9Nobxa0X1bP0oBpmmhJk+/f//P88kCSJsenZKwjRF4EFZOn0EmRpHmTpdt698vrZj9fK8ICm6jIXC4ZN7vfHbRGyHxXaM2pgbub63GFittWPN61dzAKniovsACFxZelzl1Cat5n62OXj3qGOfhkB1b1kY7/MC6/eTSJ27y7vS8NL17iEQU5Zx/HUUPfR1OZVhx/gRJKIsXnv2xG9H/N4gkNmAn1uxL2QNv6ad6+8bVYBsF100UUXp0CzWMUwaTact8fTuXJMKExrRqmnHymtgbtJ3PXoEDVTjoh7TfC647Uz/Yh4aipDw0O0ORDCL6AhHndZji9X10afA5aBUtjHZrn+bhdddNHFDMgZZNw4QTZ2pChZNFHymqzSZul84Cou/PU4AZLrJY0bHBHXE47XBK1LpnWh7XPKttcFr5tRH3Pbz7a7cxru/04ZYUPhYe6cqSPFtiyFzJ6d+ynqoosu/rUiZ5CH1p7A2UUUj+YS2jRhMyJKlsbEPeupp2uboVBHh847JioH1b2mntZUqam3fU7ZDjXB63h04OSreo/AxrwOx8n6G9FwMWld8WncP05RXUSOIeSOnblcg7aLLrr4V4vWUonC0+CdY+Pa4Q5ZuhbRm1m4u5ck0eR6SV+M4wOWlo5khLq518y9ZqH4tP/f3m7bniHHYi/tTUQsgTzfslS6sxhzyuJTEyGgYTcuh7r2xy666GKu0JLKgj5NOnaIEGkH70wbXHEvA/8WDVfkbnTX5OVSmzcW71NPjyleV3wio/S2Txtz1NTrkqbH5WR939G1jJK4suSpMpK9EwmvIa3TvnznFIgYuGHZDsbsBFw3RyENXXTRxb92FG5vMf7XoSNktpWoB5gpk4XcIQIr///27ifEruoO4Pj3d869972ZvsQYnTCRYEIYUpmFRBoGXdVAd13ZVpe1QWiKWVYLUkrvUIrYLooUq6YuFARtCy5aKaWbDLRKrS66KLY0dkwlZpKZMB3j+ObNfef+jov73sub/2/GSSPl94FhOMx973Bn8eOce3/n98P5H7L/vapgZR7d6RPS/O++xrRGuaROm1LGIJIUErQQ6fsJWlR/06IUuVxvNqY/Or7vWt7dGWvjXlz2CGW7AVvkcImAS66i5RvMjy2Sn7zpLWONMf8fVi4Vf/HPu3H+LYQM7ZSFiquu7tWHFCWtKaF4lVA8ztzs1W4CZh6jOzhDPSx/spdm0mg5XHSFYxnqaaaFoknQlk+GFubGaeYiSn4ugfuVQ++fILpniXo3ZTtZVeVj1ePRCN4r4v9AaJ3hyl0fbPsAvTHGbGDtXvr5f7+C9w91muC4zXfbUcnqBWX7t8TiKW6Nf+fd8dAfpPJzMeEIyUhzLoER5marPtj5SQnXM+MnYeTBYZyfIKs/g8a7KNsbTLpq/trwAq3mE8wee2GrrHhjjNmO6+Gv+3Lj7L++giQvEXWUUjcPkFW2tuLTgJbvoPpL2vIa82OLOZOdjhAb5CT2H/85cP5OvDyE84+AHKVsb/0cMaIkCSBTEB7mw7FLtno0xuymleEvzx2HH95LO/wY5Nuods4vbkkRgbQ2S2vpjzh+Ra35JqfuWVj3HGg3kD3z/ii++Bo++zqRE8Sy0TvJM8iczjtUH+Ty2GsrvtcYY3bB2kiUR8fBfxwn3fNzQjGBbljdp09nJQmQZAqySFieBvkLTt6mHS+RyiKxdJRxP94fBb5EZILa0CHay/XqxU/cOjjG7vPPuqLlr/mweQpWbuuNMWY3rB8gc1GeO/8NstrPCMVoFSQHLNsdY7Wa9KnDewgBNFR9dKvVaB2fgnMQ2lAG3TSNZ+0EikuA+FdieYqZV3Zem84YYzax/vY3jw75wu9pffIsiEOcDlyUVsQRoyMUyvKSom065wHrIBkxQnsZlpd08ODYPd0TOw165AKqP2UmTG/jXo0xZls2Xhbm0XHLhb0Mhadx8k1Uldh5ntjrM9qp5r3huG+K6+lBdBqUDPD5vjFU5eLTbJ6y/AHt1svMjTdta22MuVE2Xr3lonx05Bqe76O8iEsCzmkv6PWauMsm41U5jL1CE4N+vvsVUq0c01qL0H6C1L3I3G8sOBpjbqitHyzm0THy7gF88jhJ7Vto2IeuetPcW+XJjRgr3iuRi8T4JKfHzu74bo0xZhu2fv6XizI3PovwJGUxSZJdxGdVWbQYtfNWmV7zrN0aRxSRquct7k20/C4Mv3xD/xvGGNNnsLfHuSgzx+bJ0rOE9hkiUyRZwCeuU0OyIn1b452Pq+CbZHRSh14gLJ1hf/t1Zg62dnSXxhizA37gK6cmI/fcqnz8wHka8+dQvQJ6lNrQHlQFYlldGGVNy4beKrFroz7bUqXwJGmLMryDxu8RWs8xO36JuRG1Z47GmP+lwQMkwNRU5H4RFh+4xmO3vcFXH/0dZXsJn9ZIa/Wqx7QH5yIinf1ylPWDo4A4xbkqenrfojZ0haL1JzT8BIk/4jvH3mbiQCA/qUxNbqf5tTHGfGYDZn+vo9eshxRnXwAAALtJREFU+8uOO0aPojIBch/p8HGkPEQobyfGYbzXNdNEdagqIk18chHVC4Tib0TewvNnTn/xam8OSwI3xtwkOw+QcD2Adc9b73+vQcYhXLyDUu9E/GHSZBTxDaJmAGhs4uICoZyB+AGlTEOcxV+7zMzrrV4fW2OMuck+W4Bcrb8Rd34u4fCRhI9Dxp7EsdC5xgfFF8rwcOA/RwK5hF4tSAuMxpjPkd0NkP16W3BYWfJssjPu/LagaIz5nPoUBSp4D1AF9yMAAAAASUVORK5CYII=)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# ðŸš€ JohnSnowLabs Medical LLM Inference Server"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### ðŸ”„ The images required to run the llm have been pulled from \n",
    " ðŸ‘‰ [Docker Hub](https://hub.docker.com/r/johnsnowlabs/jsl-llms):\n",
    "\n",
    "\n",
    "### ðŸ³ The containers are running at system startup\n",
    "\n",
    "\n",
    "Check running the containers with:\n",
    "\n",
    "```bash\n",
    "docker ps\n",
    "```\n",
    "It should show 2 containers running, johnsnowlabs/jsl-llms:marketplace runs the model. \n",
    "ghcr.io/open-webui/open-webui:main runs webui to interact with the model.\n",
    "\n",
    "```\n",
    "CONTAINER ID   IMAGE                                COMMAND                  CREATED      STATUS                            PORTS                                         NAMES\n",
    "4dbe81768b8b   johnsnowlabs/jsl-llms:marketplace    \"./entrypoint.sh --mâ€¦\"   2 days ago   Up 2 minutes (health: starting)   0.0.0.0:8080->8080/tcp, [::]:8080->8080/tcp   med-llm-cmp-jsl-llms-1\n",
    "684bf3801bf8   ghcr.io/open-webui/open-webui:main   \"bash start.sh\"          2 days ago   Up 2 minutes (healthy)            0.0.0.0:3000->8080/tcp, [::]:3000->8080/tcp   open-webui\n",
    "```\n",
    "---\n",
    "\n",
    "### ðŸ“œ View Container Logs\n",
    "\n",
    "You can monitor the container logs with:\n",
    "\n",
    "```bash\n",
    "docker logs <container-id>\n",
    "```\n",
    "\n",
    "The logs will show important information such as:\n",
    "- Model initialization and loading progress\n",
    "- License validation status\n",
    "- Server startup confirmation\n",
    "- Memory usage and GPU configuration\n",
    "- Model task capabilities\n",
    "- Available API endpoints and routes\n",
    "- Health check status\n",
    "\n",
    "\n",
    "Example log entry for successful startup of johnsnowlabs/jsl-llms:marketplace:\n",
    "```bash\n",
    "INFO: Application startup complete.\n",
    "llm-service [INFO] Server is healthy and model is loaded\n",
    "INFO: Started server process [1]\n",
    "INFO:     127.0.0.1:42154 - \"GET /health HTTP/1.1\" 200 OK\n",
    "```\n",
    "\n",
    "Once you see these messages, the service is ready to accept requests! ðŸŽ‰"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Imports"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "import json\n",
    "import requests"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Initial setup"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "prompt1 = \"How do emerging mRNA technologies compare to traditional vaccine approaches for disease prevention?\"\n",
    "\n",
    "prompt2 = \"\"\"Patients with xeroderma pigmentosum develop skin cancer when they are exposed to sunlight because they have a deficiency in:\n",
    "\n",
    "A. An enzyme essential to repair mismatched bases.\n",
    "B. UV specific endonuclease.\n",
    "C. DNA polymerase I.\n",
    "D. DNA polymerase III.\n",
    "E. Glycosylase that removes uracil bases from DNA.\"\"\"\n",
    "\n",
    "system_prompt = \"\"\"You are a medical expert that reviews the problem, does reasoning, and then gives a final answer.\n",
    "Strictly follow this exact format for giving your output: /think\n",
    "\n",
    "**Final Answer**: [Conclusive Answer]\"\"\""
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Health & Version:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Health: 200 \n"
     ]
    }
   ],
   "source": [
    "url = \"http://localhost:8080/health\"\n",
    "response = requests.get(url)\n",
    "print(\"Health:\", response.status_code, response.text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Ping: 200 \n"
     ]
    }
   ],
   "source": [
    "url = \"http://localhost:8080/ping\"\n",
    "response = requests.post(url)\n",
    "print(\"Ping:\", response.status_code, response.text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Version: {'version': '0.9.2'}\n"
     ]
    }
   ],
   "source": [
    "url = \"http://localhost:8080/version\"\n",
    "response = requests.get(url)\n",
    "print(\"Version:\", response.json())"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Core Functionality:"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### List available models"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "url = \"http://localhost:8080/v1/models\"\n",
    "response = requests.get(url)\n",
    "print(\"Models:\", response.json())"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Non-Streaming Responses"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "def get_completion_response(url, payload):\n",
    "    \"\"\"\n",
    "    Handles non-streaming responses from both `/v1/chat/completions` and `/v1/completions`.\n",
    "\n",
    "    Args:\n",
    "        url (str): The endpoint URL.\n",
    "        payload (dict): The request payload.\n",
    "\n",
    "    Returns:\n",
    "        str: The generated text (chat or completion).\n",
    "    \"\"\"\n",
    "    response = requests.post(url, json=payload)\n",
    "\n",
    "    if response.status_code == 200:\n",
    "        data = response.json()\n",
    "        \n",
    "        choices = data.get(\"choices\", [{}])\n",
    "\n",
    "        res = dict()\n",
    "        if \"message\" in choices[0]:\n",
    "            res[\"content\"] = choices[0][\"message\"].get(\"content\", \"\")\n",
    "            res[\"reasoning_content\"] = choices[0][\"message\"].get(\"reasoning_content\", \"\")\n",
    "            return res\n",
    "\n",
    "        return choices[0].get(\"text\", \"\")\n",
    "    else:\n",
    "        print(\"Error:\", response.status_code, response.text)\n",
    "        return \"\""
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Chat completions"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "reasoning: \n",
      "Okay, I need to compare emerging mRNA technologies with traditional vaccine approaches for disease prevention. Let me start by recalling what I know about both.\n",
      "\n",
      "Traditional vaccines usually use weakened or inactivated pathogens, or parts of them like proteins or polysaccharides. These stimulate the immune system to recognize and attack the actual pathogen if encountered later. Examples include the measles, flu shots, and HPV vaccines.\n",
      "\n",
      "mRNA vaccines, on the other hand, use a piece of messenger RNA that instructs cells to produce a specific protein (like the spike protein in the case of COVID-19 vaccines). The immune system then recognizes this protein as foreign and mounts an immune response. The mRNA doesn't enter the nucleus and doesn't integrate into the genome, so it doesn't alter DNA.\n",
      "\n",
      "Advantages of mRNA vaccines: They can be developed more quickly because they don't require growing the pathogen. This is why they were so fast for COVID-19. They can be easily modified if the pathogen mutates. Also, they might have better safety profiles since they don't contain live pathogens.\n",
      "\n",
      "Disadvantages: mRNA vaccines need special storage conditions, like ultra-cold temperatures, which can be a challenge for distribution. They might have shorter shelf lives compared to traditional vaccines. Also, there's less long-term data on their safety and efficacy since they're newer.\n",
      "\n",
      "Traditional vaccines have been around longer, so their safety and efficacy are well-established. They can be more stable and easier to store and transport. However, they might take longer to develop, especially for new pathogens, because of the need to grow and purify the pathogen or its components.\n",
      "\n",
      "I should also consider examples. For instance, the Pfizer and Moderna COVID-19 vaccines are mRNA-based, while the traditional flu shot uses inactivated virus. Each has their own pros and cons.\n",
      "\n",
      "Another point is the immune response. mRNA vaccines might induce a strong immune response because they mimic an infection more closely by instructing cells to produce the antigen. Traditional vaccines might not always trigger as robust a response, depending on the antigen used.\n",
      "\n",
      "Cost and production scale might be factors too. Traditional vaccines might be cheaper to produce, while mRNA vaccines require more advanced manufacturing facilities.\n",
      "\n",
      "I need to make sure I cover these points clearly, compare them side by side, and conclude with a summary of how they differ in terms of development time, safety, efficacy, production, storage, and application.\n",
      "\n",
      "response: \n",
      "\n",
      "**Final Answer**: Emerging mRNA technologies offer several advantages over traditional vaccine approaches, including faster development times, adaptability to pathogen mutations, and the potential for robust immune responses. They avoid using live pathogens, enhancing safety, but require specialized storage and have less long-term data compared to traditional vaccines. Traditional vaccines, while well-established, are often slower to develop and may not adapt as quickly to new or evolving pathogens. Both approaches have distinct strengths, with mRNA vaccines excelling in rapid response and flexibility, while traditional vaccines benefit from proven safety profiles and stability.\n"
     ]
    }
   ],
   "source": [
    "url = \"http://localhost:8080/v1/chat/completions\"\n",
    "payload = {\n",
    "    \"model\": \"Medical-LLM-Small\",\n",
    "    \"messages\": [\n",
    "        {\"role\": \"system\", \"content\": system_prompt},\n",
    "        {\"role\": \"user\", \"content\": prompt1}\n",
    "    ],\n",
    "    \"max_tokens\": 2048,\n",
    "    \"temperature\": 0.8,\n",
    "    \"top_p\": 0.95,\n",
    "}\n",
    "\n",
    "response = get_completion_response(url, payload)\n",
    "print(f\"reasoning: {response['reasoning_content']}\")\n",
    "print(f\"response: {response['content']}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "For additional parameters and details, refer to:\n",
    "\n",
    "- [ChatCompletionRequest](https://github.com/vllm-project/vllm/blob/v0.8.5/vllm/entrypoints/openai/protocol.py#L232)\n",
    "- [OpenAIâ€™s Chat Completions API](https://platform.openai.com/docs/api-reference/chat/create)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Text completions"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "response:  **Review and Reasoning**: Xeroderma pigmentosum (XP) is a rare genetic disorder characterized by an extreme sensitivity to ultraviolet (UV) light, which leads to an increased risk of skin cancer. This condition is caused by a deficiency in the enzyme responsible for repairing UV-induced DNA damage, specifically the enzyme involved in nucleotide excision repair (NER). This enzyme is called UV-specific endonuclease. In individuals with XP, the deficiency in this enzyme leads to an inability to repair the damage caused by UV radiation, resulting in the accumulation of DNA mutations and an increased risk of skin cancer when exposed to sunlight. The other options are not correct because:\n",
      "\n",
      "A. An enzyme essential to repair mismatched bases: This is not directly related to the specific enzyme deficiency in XP.\n",
      "B. UV specific endonuclease: This is the correct answer and is the enzyme responsible for repairing UV-induced DNA damage.\n",
      "C. DNA polymerase I: This is an enzyme involved in DNA replication and repair, but not the specific enzyme responsible for repairing UV-induced DNA damage in XP.\n",
      "D. DNA polymerase III: This is an enzyme involved in DNA replication, but not the specific enzyme responsible for repairing UV-induced DNA damage in XP.\n",
      "E. Glycosylase that removes uracil bases from DNA: This is an enzyme involved in base excision repair, but not the specific enzyme responsible for repairing UV-induced DNA damage in XP. **Final Answer**: B. UV specific endonuclease.\n"
     ]
    }
   ],
   "source": [
    "url = \"http://localhost:8080/v1/completions\"\n",
    "payload = {\n",
    "    \"model\": \"Medical-LLM-Small\",\n",
    "    \"prompt\": f\"{system_prompt}\\n\\nUser: {prompt2}\\n\\nAssistant:\",\n",
    "    \"max_tokens\": 2048,\n",
    "    \"temperature\": 0.8,\n",
    "    \"top_p\": 0.95,\n",
    "}\n",
    "\n",
    "response = get_completion_response(url, payload)\n",
    "\n",
    "print(f\"response: {response}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "For further details and additional parameters, see:\n",
    "\n",
    "- [CompletionRequest](https://github.com/vllm-project/vllm/blob/v0.8.5/vllm/entrypoints/openai/protocol.py#L730)\n",
    "- [OpenAIâ€™s Completions API](https://platform.openai.com/docs/api-reference/completions/create)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Streaming Responses"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "def stream_response(url, payload):\n",
    "    \"\"\"\n",
    "    Handles streaming responses from both `/v1/chat/completions` and `/v1/completions`.\n",
    "\n",
    "    Args:\n",
    "        url (str): The API endpoint URL.\n",
    "        payload (dict): The JSON payload for the request.\n",
    "\n",
    "    Prints the reconstructed streamed output in real-time.\n",
    "    \"\"\"\n",
    "    response = requests.post(url, json=payload, stream=True)\n",
    "\n",
    "    for chunk in response.iter_lines():\n",
    "        if chunk:\n",
    "            decoded = chunk.decode(\"utf-8\")\n",
    "            if decoded.startswith(\"data: \"):\n",
    "                data = decoded[len(\"data: \"):]\n",
    "                if data.strip() == \"[DONE]\":\n",
    "                    break\n",
    "                try:\n",
    "                    parsed = json.loads(data)\n",
    "                    choices = parsed.get(\"choices\", [])\n",
    "                    if not choices:\n",
    "                        continue\n",
    "                    choice = choices[0]\n",
    "\n",
    "                    content = choice.get(\"delta\", {}).get(\"content\") or choice.get(\"text\")\n",
    "                    if content:\n",
    "                        print(content, end=\"\", flush=True)\n",
    "                except (KeyError, json.JSONDecodeError):\n",
    "                    continue\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Chat completions"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\n",
      "**Final Answer**: Emerging mRNA technologies offer faster development timelines, adaptability to new variants, and the absence of live viral components, which can enhance safety. However, they require cold chain storage and distribution, which can be logistically challenging. Traditional vaccines, while slower to develop and less adaptable to mutations, have a long-established safety profile, proven efficacy, and easier storage/distribution. The choice between them depends on the disease, context, and resource availability."
     ]
    }
   ],
   "source": [
    "url = \"http://localhost:8080/v1/chat/completions\"\n",
    "\n",
    "payload = {\n",
    "    \"model\": \"Medical-LLM-Small\",\n",
    "    \"messages\": [\n",
    "        {\"role\": \"system\", \"content\": system_prompt},\n",
    "        {\"role\": \"user\", \"content\": prompt1}\n",
    "    ],\n",
    "    \"max_tokens\": 2048,\n",
    "    \"temperature\": 0.8,\n",
    "    \"top_p\": 0.95,\n",
    "    \"stream\": True\n",
    "}\n",
    "\n",
    "stream_response(url, payload)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Text completions"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<think>\n",
      "Okay, let's see. The question is about xeroderma pigmentosum and why patients develop skin cancer when exposed to sunlight. The options are all enzymes or proteins related to DNA repair.\n",
      "\n",
      "First, I remember that xeroderma pigmentosum is a genetic disorder where the body can't repair DNA damage caused by UV light. So the main issue here is DNA repair deficiency.\n",
      "\n",
      "The key part is the enzyme involved. The options mention different enzymes. Let me recall: Xeroderma pigmentosum is associated with defects in nucleotide excision repair (NER). The NER pathway is responsible for removing bulky DNA lesions, like those caused by UV-induced thymine dimers.\n",
      "\n",
      "Looking at the options, option A says \"an enzyme essential to repair mismatched bases.\" Wait, mismatch repair (MMR) is different from NER. MMR deals with base mismatches and small insertions/deletions, not the bulky lesions from UV. So maybe not A.\n",
      "\n",
      "Option B is \"UV specific endonuclease.\" The NER process involves several enzymes. One step is the recognition of damage, followed by incision by endonucleases. The XPG protein is involved in the endonuclease activity during NER. But is there a specific UV-specific endonuclease? Or is this part of the NER complex?\n",
      "\n",
      "Option C and D are DNA polymerases I and III. Those are involved in DNA replication and repair, but not specifically the NER pathway. Polymerase I is more about gap-filling in repair, but the primary issue in XP is the excision part.\n",
      "\n",
      "Option E is glycosylase that removes uracil. That sounds like uracil-DNA glycosylase, which is part of base excision repair (BER), not NER. So that's not related to UV damage.\n",
      "\n",
      "Back to option A: the enzyme for repair of mismatched bases. If the question is about UV damage, which causes thymine dimers, which are bulky lesions, not mismatches. So the correct pathway is NER. The enzyme involved in NER is the endonuclease, which makes cuts around the damaged site. So maybe option B? But wait, the XPG gene is part of the NER pathway. However, the question says \"UV specific endonuclease.\" Alternatively, the main defect in XP is the lack of the XPA protein, which is involved in recognizing the damage. But the answer options don't mention XPA. The options are about enzymes that repair mismatched bases, endonucleases, polymerases, or glycosylases.\n",
      "\n",
      "Wait, maybe I was wrong. Another thought: Xeroderma pigmentosum is caused by defects in the nucleotide excision repair (NER) pathway. The key enzymes here are the endonucleases that cut the DNA strand around the damaged site. So in XP, the patients can't repair the UV-induced lesions because the NER pathway is defective. The enzyme involved in NER is the endonuclease, so option B. But I need to be careful. The answer might be A if the question is about the enzyme that repairs mismatched bases. Wait, no, because UV causes thymine dimers, which are not mismatches. The NER pathway is for bulky lesions, not base mismatches. The MMR is for base mismatches. So the answer is B? Or maybe the question is referring to the XPG protein, which is an endonuclease. But the options don't specify XPG. The options are general. The answer would be B. Alternatively, perhaps the correct answer is A, but I'm getting confused here. Let me check.\n",
      "\n",
      "Wait, the correct answer is that patients with xeroderma pigmentosum have a deficiency in an enzyme involved in DNA repair, specifically the nucleotide excision repair pathway. The enzyme in question is the endonuclease that recognizes and cuts the DNA around the UV damage. So the answer would be B. However, I need to confirm. Alternatively, some sources say that the main issue is the lack of the XP protein, which is a key component in NER. But the options don't list that. The closest is option B, UV specific endonuclease. Therefore, the answer is B.\n",
      "</think>\n",
      "\n",
      "**Final Answer**: B. UV specific endonuclease."
     ]
    }
   ],
   "source": [
    "url = \"http://localhost:8080/v1/completions\"\n",
    "\n",
    "payload = {\n",
    "    \"model\": \"Medical-LLM-Small\",\n",
    "    \"prompt\": f\"{system_prompt}\\n\\nUser: {prompt2}\\n\\nAssistant:\",\n",
    "    \"max_tokens\": 2048,\n",
    "    \"temperature\": 0.8,\n",
    "    \"top_p\": 0.95,\n",
    "    \"stream\": True\n",
    "}\n",
    "\n",
    "stream_response(url, payload)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "\n",
    "## Additional Endpoints  \n",
    "You can access other API routes depending on the model's capabilities. Check your server startup logs for supported tasks and their corresponding endpoints.\n",
    "\n",
    "The full list of available routes is logged during service initialization."
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
